StockpollyBeta
Get App
Popularity #2,734
FLGT · NASDAQ · Medical - Diagnostics & Research

Fulgent Genetics (FLGT)

Combines hereditary-cancer and pathology testing with a nanoencapsulated cancer-drug pipeline in clinical trials.

$21.65
After hours+0.01 (+0.05%)
At close$21.64(+0.46%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue857164717276738284837185
Cost of revenue454542454544454749515060
Gross profit402522262732283436332126
4017644454448485451695660
Research & development101211131212121314141415
284230303034343935534042
Selling & marketing10119991081212111215
General & administrative173221212124252623422827
Other expenses21222222222223
Operating income0−151−22−19−17−16−20−20−15−36−35−34
7688−188−29794
Interest income668888888796
Interest expense000000000000
Other non-operating income−7−120−8−81−8−82−9−7−9−4
Income before tax7−145−14−11−19−8−12−22−6−29−26−30
Income tax expense20−110−2−4−20−21−6−10
Net income from continuing operations−13−134−14−9−15−6−12−19−7−24−25−30
Net income−13−128−13−9−15−6−12−19−7−23−25−30
EPS, basic−$0.44−$4.30−$0.45−$0.29−$0.48−$0.19−$0.37−$0.61−$0.21−$0.76−$0.80−$1.05
EPS, diluted−$0.44−$4.30−$0.45−$0.29−$0.48−$0.19−$0.37−$0.61−$0.21−$0.76−$0.80−$1.05
Weighted average shares, basic303030303031313131313128
Weighted average shares, diluted303030303031313131313128
EBITDA13−24−8−5−13−2−6−150−23−20−22
Depreciation & amortization677666666668
EBIT7−31−14−11−19−8−12−22−6−29−26−30